A proof-of-concept study for the pathogenetic role of enhancer hypomethylation of MYBPHL in multiple myeloma
Abstract Enhancer DNA methylation and expression of MYBPHL was studied in multiple myeloma (MM). By bisulfite genomic sequencing, among the three CpGs inside the MYBPHL enhancer, CpG1 was significantly hypomethylated in MM cell lines (6.7–50.0%) than normal plasma cells (37.5–75.0%) (P = 0.007), whi...
Guardado en:
Autores principales: | Kwan Yeung Wong, Gareth J. Morgan, Eileen M. Boyle, Alfred Sze Lok Cheng, Kevin Yuk-Lap Yip, Chor Sang Chim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d58c3083d67245f89af33385adaad2f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Proof of the concept to use a malignant B cell line drug screen strategy for identification and weight of melphalan resistance genes in multiple myeloma.
por: Martin Bøgsted, et al.
Publicado: (2013) -
Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact
por: Till Braun, et al.
Publicado: (2021) -
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
por: Eileen M. Boyle, et al.
Publicado: (2021) -
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
por: Hussein Ghamlouch, et al.
Publicado: (2021) -
Conception of understanding in mathematical proof
por: V. V. Tselishchev, et al.
Publicado: (2021)